A site where you can find recommended contractors for non-clinical testing｜effical " Non-Clinical CROs and Agencies " Axis Bioservices Ltd.

Axis Bioservices Ltd.

Table of Contents

This article introduces Axis Bioservices Ltd., which operates as a contract research organization (CRO) specializing in non-clinical studies. We have researched and summarized the characteristics of the company's contract non-clinical study services, as well as examples of the company's proprietary pathological models.

Axis Bioservices Ltd.' Contract Non-clinical Trial Services Feature

Provides specialized services related to cancer, inflammation, and respiratory diseases

Axis Bioservices Ltd.' strength lies in its specialized services related to oncology, inflammation, and respiratory diseases. Particularly in the area of oncology, Axis Bioservices Ltd. strongly supports the early stages of drug discovery programs by providing a wide range of cell line-derived models and offering in vivo testing services that can be customized. We target a variety of companies and institutions, including pharmaceutical and biotech companies, universities, and other research institutions.

Listen to your clients.

The company will listen to its clients and provide guidance and advice at each step of the preclinical efficacy testing process. By doing so, the company aims to provide better results in a cost-effective manner. In fact, the company's clients have praised the company for its excellent communication and good advice*.

Reference: Axis Bioservices Ltd. official websitehttps://www.axisbio.co.uk/

Specialized facilities and highly skilled staff

As a CRO with strengths in oncology, inflammation, and respiratory diseases, the company is unique in that it has its own specialized SPF (Specific Pathogen Free) breeding and research facilities, as well as a highly skilled staff to provide tailored solutions. The company is also characterized by its highly skilled staff.

3 Specialized Pre-clinical CROs for Advanced Drug Discovery

An example of Axis Bioservices Ltd.' disease state models

Axis Bioservices Ltd. offers a variety of models for oncology research. For example, we have a wide range of tumor cell lines that can be transplanted into immunocompromised mice and rats for use in measuring the efficacy of new therapeutic agents. Specifically, the company possesses a very wide variety of cell lines, including those for the bladder, brain, bone, cervix, stomach, and liver, and is well-positioned to meet a variety of research needs. The company has also developed its own luciferase-expressing cell line collection for breast cancer, glioma, ovarian cancer, pancreatic cancer, and other cancers, which can be used for allogeneic transplantation and metastasis evaluation.

Axis Bioservices Ltd. Non-clinical Case Studies

No specific case studies were available on the official website.

Axis Bioservices Ltd. Company Information

Axis Bioservices Ltd. was founded in 2013. Since its inception, it has served a diverse client base in the UK, Europe, the Middle East, and North America.

Address	189 Castleroe Road, Coleraine, County Londonderry, Northern Ireland BT51 3RP
Tel	+44 2870 868596
Website	https://www.axisbio.co.uk

3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation

SMC Laboratories, Inc.

Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)

SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.
With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.

Consult study design and disease model development
with SMC Laboratories, Inc.

Consult SMC Laboratories
Call us

Safety Studies
Comprehensive Safety Evaluation for FIH Applications

Labcorp Holdings Inc.
(Labcorp Drug Development)

Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)

Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.

Consult Labcorp Holdings Inc.
Discuss GLP/ICH-compliant study design for your FIH submission.

To labcorp.
Call us

Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation

PhoenixBio Co., Ltd.

Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)

PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.
The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus

Phoenix Bio.
Call us